Stam, Jord C.
de Maat, Steven
de Jong, Dorien
Arens, Mathia
van Lint, Fenna
Gharu, Lavina
van Roosmalen, Mark H.
Roovers, Rob C.
Strokappe, Nika M.
Wagner, Ralf
Kliche, Alexander
de Haard, Hans J.
van Bergen en Henegouwen, Paul M.
Nijhuis, Monique
Verrips, C. Theo
Funding for this research was provided by:
Bill and Melinda Gates Foundation (51759, 38637)
HH Target2cure (LSHM19101-SGF)
Article History
Received: 3 February 2022
Accepted: 4 July 2022
First Online: 4 August 2022
Competing interests
: The authors declare no competing interests.